Publication: Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions
Issued Date
2018-08-01
Resource Type
ISSN
18157920
10273719
10273719
Other identifier(s)
2-s2.0-85049753635
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Tuberculosis and Lung Disease. Vol.22, No.8 (2018), 912-917
Suggested Citation
V. X. Nam, N. V. Nhung, N. B. Hoa, H. T.T. Thuy, N. T.M. Phuong, N. T. Anh, L. T. Ngoc Anh, V. Q. Trung, T. V. Ha, A. Meeyai, M. Thavorncharoensap, U. Chaikledkaew Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions. International Journal of Tuberculosis and Lung Disease. Vol.22, No.8 (2018), 912-917. doi:10.5588/ijtld.18.0039 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/46470
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions
Abstract
© 2018 The Union. S E T T I N G: Multidrug-resistant tuberculosis (MDR-TB) has become a major worldwide health problem. Various studies have been conducted on the cost of MDR-TB treatment; however, this has remained largely unexplored in Viet Nam. O B J E C T I V E: To estimate the total cost of MDR-TB treatment at several health care facilities in Viet Nam. D E S I G N: A prospective, prevalence-based study was conducted at three selected centers from March to June 2016 in 204 patients, 102 of whom were treated for 9 months and 102 for 20 months. Direct medical costs were calculated using electronic hospital databases, while a questionnaire was used to interview participants for evaluating direct non-medical and indirect costs. Total costs were estimated from a societal perspective in 2017 USD. R E S U L T S: Patients were mostly males aged 25–44 years. The average length of hospitalization in the 9-month treatment group was 168 6 127 days; in the 20-month group, it was 671 6 119 days. The average treatment cost for MDR-TB was respectively US$1480.34 6 211.61 and US$2695.58 6 294.98 for the 9- and 20-month treatment groups. Direct medical costs generally accounted for the highest proportion of the total costs, while the cost of pharmaceuticals and materials comprised the highest direct cost. C O N C L U S I O N: There was a significant difference in total costs among the three hospitals in the 9- and 20-month treatment groups.